Leukemia inhibitory factor improves survival of retroviral vector-infected hematopoietic stem cells in vitro, allowing efficient long-term expression of vector-encoded human adenosine deaminase in vivo.
J Exp Med (1991) 174 (4): 837–845.
Currently there are no citedby results. Try again later.
